Elicio Therapeutics, Inc. (ELTX) Discusses Camupepimut Development in Neoadjuvant and Metastatic Pancreatic Cancer Transcript

🇺🇸 Seeking Alpha (US) —

AI Summary

The article is a transcript in which Elicio Therapeutics discusses camupepimut development for neoadjuvant and metastatic pancreatic cancer. No trial results or other development details are included in the supplied text.

Markets Health Elicio Therapeutics camupepimut pancreatic cancer cancer therapy clinical development metastatic cancer

Read original source →